Caplin Point Laboratories

BSE : 524742 | NSE : CAPLIPOINT

Industry : Pharma Formulations | ISIN : INE475E01026 | FreeFloat : 30.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)3,133.01
Net Worth (NW)1,347.38
Intrinsic Worth (IW)4,480.39
Market Cap (MC)6,688.71
Economic Value Added27.00
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)69.93%
IC Gross Margin (EBITDA/IC)13.44%
IC Net Margin (NPT/IC)9.67%
Knowledge Turnover (Sales/IC)0.40
Market to Intrinsic Value (MC/IW)1.49

As OfIntrinsic ValueMarket Price
30 Sep 2021Rs. 592.31Rs. 884.25
6 Dec 2021 ---- Rs. 777.75
-32.20     -4.14%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 774.45ReduceBuy on Dips
KB > 50% : Yes50 DMA : Rs. 850.88
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-18
C
159.03
166.77
65.50
59.82
59.81
45.81
46.53
Mar-19
C
187.34
190.01
67.43
60.71
60.69
49.86
45.53
Jun-19
C
192.55
197.02
71.94
64.55
64.45
50.07
49.70
Sep-19
C
227.20
234.10
78.01
70.60
70.52
57.27
61.79
Dec-19
C
228.21
238.55
78.11
69.68
69.62
58.84
60.10
Mar-20
C
215.23
234.87
73.44
65.03
64.87
48.86
60.18
Jun-20
C
240.08
246.57
78.09
69.13
68.62
54.55
54.54
Sep-20
C
268.12
269.88
89.19
80.31
79.83
62.83
56.21
Dec-20
C
274.39
280.21
89.75
80.48
80.20
66.14
62.78
Mar-21
C
278.71
288.17
95.15
85.29
84.97
67.92
70.43
Jun-21
C
300.44
309.65
101.82
89.79
89.52
71.53
76.47
Sep-21
C
303.53
312.02
109.66
97.94
97.73
76.82
76.82
* C - Consolidated, S - Standalone